AU2005319174A1 - Group B Streptococcus - Google Patents

Group B Streptococcus Download PDF

Info

Publication number
AU2005319174A1
AU2005319174A1 AU2005319174A AU2005319174A AU2005319174A1 AU 2005319174 A1 AU2005319174 A1 AU 2005319174A1 AU 2005319174 A AU2005319174 A AU 2005319174A AU 2005319174 A AU2005319174 A AU 2005319174A AU 2005319174 A1 AU2005319174 A1 AU 2005319174A1
Authority
AU
Australia
Prior art keywords
pct
nucleic acid
polypeptide
nem316
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005319174A
Other languages
English (en)
Inventor
Vega Masignani
Herve Tettelin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
J Craig Venter Institute Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
J Craig Venter Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc, J Craig Venter Institute Inc filed Critical Novartis Vaccines and Diagnostics Inc
Publication of AU2005319174A1 publication Critical patent/AU2005319174A1/en
Assigned to NOVARTIS VACCINES AND DIAGNOSTICS INC., J. CRAIG VENTER INSTITUTE, INC. reassignment NOVARTIS VACCINES AND DIAGNOSTICS INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: NOVARTIS VACCINES AND DIAGNOSTICS INC.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2005319174A 2004-12-22 2005-12-21 Group B Streptococcus Abandoned AU2005319174A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63894304P 2004-12-22 2004-12-22
US60/638,943 2004-12-22
US64043804P 2004-12-30 2004-12-30
US60/640,438 2004-12-30
PCT/US2005/046491 WO2006069200A2 (en) 2004-12-22 2005-12-21 Group b streptococcus

Publications (1)

Publication Number Publication Date
AU2005319174A1 true AU2005319174A1 (en) 2006-06-29

Family

ID=36602309

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005319174A Abandoned AU2005319174A1 (en) 2004-12-22 2005-12-21 Group B Streptococcus

Country Status (8)

Country Link
US (1) US20090104218A1 (enExample)
EP (1) EP1828231A2 (enExample)
JP (1) JP2008525033A (enExample)
AU (1) AU2005319174A1 (enExample)
CA (1) CA2591510A1 (enExample)
IL (1) IL183830A0 (enExample)
MX (1) MX2007007033A (enExample)
WO (1) WO2006069200A2 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
EA004444B1 (ru) 1998-12-22 2004-04-29 Майкросайенс Лимитед Гены и белки и их применение
ATE439372T1 (de) 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2006042027A2 (en) * 2004-10-08 2006-04-20 Novartis Vaccines And Diagnostics Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
EP1801235A1 (en) * 2005-12-20 2007-06-27 Institut Pasteur Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
WO2008020308A2 (en) * 2006-06-19 2008-02-21 Mutabilis Sa Identification of genes implicated in the virulence of streptococcus agalactiae
EP2063911A2 (en) * 2006-07-26 2009-06-03 Novartis Ag Immunogenic compositions for gram positive bacteria
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
EP2135877A1 (en) 2008-06-19 2009-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
US8147849B2 (en) 2009-02-20 2012-04-03 Novartis Ag Protective antigens for group B Streptococcus hypervirulent strains
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
CN107126557A (zh) 2009-06-29 2017-09-05 健诺西生物科学公司 抗肺炎链球菌的疫苗和组合物
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
KR20140026372A (ko) * 2011-02-02 2014-03-05 이무노퓨처 아이앤씨. 혈액-뇌 장벽을 투과하는 약물 전달체, 펩티드 및 이의 용도
EP2557424A1 (en) 2011-08-11 2013-02-13 InGen Biosciences Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
WO2013124473A1 (en) * 2012-02-24 2013-08-29 Novartis Ag Pilus proteins and compositions
EP2831250B1 (en) * 2012-03-30 2021-11-24 DuPont US Holding, LLC Enzymes useful for peracid production
AR092896A1 (es) 2012-10-03 2015-05-06 Novartis Ag Composiciones inmunogenicas
WO2015008214A1 (en) * 2013-07-16 2015-01-22 Universite De Lausanne Bacterial lysins and uses thereof
US10245310B2 (en) * 2014-08-05 2019-04-02 Glaxosmithkline Biologicals Sa Carrier molecule for antigens
AU2017214441B2 (en) 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases
WO2018204153A1 (en) * 2017-05-02 2018-11-08 Venomyx, Inc. Composition and methods for treating snake envenomation
WO2018237010A2 (en) * 2017-06-20 2018-12-27 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Vaccine compositions and methods of using the same
PL239045B1 (pl) * 2018-01-09 2021-11-02 Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
CA3103442A1 (en) * 2018-06-13 2019-12-19 Gen-Probe Incorporated Compositions and methods for detecting group b streptococcus nucleic acid
KR20210055694A (ko) 2018-08-06 2021-05-17 메디카인 인코포레이티드 Il-2 수용체 결합 화합물
KR20220110207A (ko) 2019-11-05 2022-08-05 메디카인 인코포레이티드 IL-2RβγC 결합 화합물
CA3160722A1 (en) * 2019-12-06 2021-06-10 Theratechnologies Inc. Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer
US11746139B2 (en) 2020-02-03 2023-09-05 Medikine, Inc. IL-7Rαγc binding compounds
US20230127948A1 (en) * 2020-02-12 2023-04-27 The Broad Institute, Inc. Field deployable crispr-cas diagnostics and methods of use thereof
US11639523B2 (en) 2020-03-23 2023-05-02 The Broad Institute, Inc. Type V CRISPR-Cas systems and use thereof
WO2022026534A1 (en) * 2020-07-28 2022-02-03 Kansas State University Research Foundation Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
EP4268901A3 (en) * 2020-11-04 2024-01-17 Medikine, Inc. Il-2r beta-gamma c binding compounds and uses thereof
US11999771B2 (en) 2022-04-07 2024-06-04 Medikine, Inc. IL-7Rαγc ligand immunoglobulin fusion proteins
WO2025017062A1 (en) * 2023-07-18 2025-01-23 Intervet International B.V. New type of streptococcus agalactiae serotype ia bacterium and vaccines thereof
WO2025151408A1 (en) * 2024-01-08 2025-07-17 Denali Therapeutics Inc. Compositions and methods for modulating tau expression
WO2025250877A1 (en) * 2024-05-31 2025-12-04 Saliogen Therapeutics, Inc. Mobile genetic elements from myotis myotis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
GB9808327D0 (en) * 1998-04-20 1998-06-17 Chiron Spa Antidiotypic compounds
EP1100920A2 (en) * 1998-07-27 2001-05-23 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
ATE439372T1 (de) * 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
EP2314603A3 (en) * 2002-10-15 2011-05-18 Intercell AG Nucleic acids coding for adhesion factors of group B streptococcus, adhesion factors of group B streptococcus and futher uses thereof
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741

Also Published As

Publication number Publication date
CA2591510A1 (en) 2006-06-29
IL183830A0 (en) 2007-10-31
MX2007007033A (es) 2007-08-03
WO2006069200A2 (en) 2006-06-29
WO2006069200A3 (en) 2007-03-01
US20090104218A1 (en) 2009-04-23
JP2008525033A (ja) 2008-07-17
EP1828231A2 (en) 2007-09-05

Similar Documents

Publication Publication Date Title
US20090104218A1 (en) Group B Streptococcus
US8039007B2 (en) Polypeptides from Neisseria meningitidis
EP2351773A1 (en) Polypeptides from non-typeable haemophilus influenzae
EP1871888A2 (en) Haemophilus influenzae type b
ES2661815T3 (es) Polipéptidos quiméricos, híbridos y en tándem de NMB1870 meningocócico
US20120070457A1 (en) Polypeptides from neisseria meningitidis
IL280189B2 (en) Modified meningococcal FHBP polypeptides
US20110052620A1 (en) Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus
US8034349B2 (en) Peptides that mimic non-human cross-reactive protective epitopes of the group B meningococcal capsular polysaccharide
CN101213205A (zh) B族链球菌
AU2012203509A1 (en) Polypeptides from Neisseria meningitides
WO2013030783A1 (en) Immunogenic proteins and compositions
Creasy Daugherty et al.(43) Pub. Date: Mar. 22, 2012
HK1160659A (en) Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application